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Date: 10-18-2013 Medulloblastoma, the most common malignant brain tumor in children, occurs primarily during the first decase of life. Early childhood is the period of most rapid brain growth. We hypothesized that the mechanisms that support developmental brain growth in early life can also play a key role in medulloblastoma formation. We therefore tested whether Aspm, a gene that when deleted causes reduced brain growth, is essential for medulloblastoma tumorigenesis. The performance of this investigation under the mentorship of Dr. Timothy Gershon, presented Dr. Garcia with an ideal opportunity to develop scientific independence.
In the first year of the project, Dr. Garcia made substantial progress toward her 3 Specific Aims.
Aim 1 was to determine the role of Aspm in neural progenitor function. Dr. Garcia analyzed mice with Aspm deletion at successive ages. Dr. Garcia determined that Aspm deletion in mice does limit brain growth, as it does in humans with hereditary microcephaly (see Fig 1, 2 attached manuscript). Importantly, Dr. Garcia made the surprising discovery that Aspm deletion does not reduce growth by decreasing the rate of neural progenitor proliferation, but rather by increasing the frequency with which progenitors undergo cell death (see Fig. 3 ,4 attached manuscript). Moreover, Dr. Garcia identified increased replication stress as the cause of cell death in Aspmdeleted progenitors (see Fig. 4 sttached manuscript). These findings provide a new perspective on the relationship between Aspm and progenitor proliferation and informed the investigations for Aim 2.
Aim 2 was to determine the role of Aspm in medulloblastoma. Dr. Garcia developed expertise in microscopy and real-time PCR and used these techniques to demonstrate Aspm up-regulation in medulloblastomas that form spontaneously in genetically engineered mice (see Fig.1 attached manuscript). Dr Garcia then interbred these medulloblastoma-prone mice with the Aspm deleted mice that she had generated and found that Aspm loss reduced tumor growth (see Fig. 6 . attached manuscript ). As in brain progentiros, Dr. Garcia forund that Aspm deletion increased the replication stress of tumor cells. Dr Garcia has worked with Dr. Gershon, here mentor, to generate a manuscript describing her findings from Aims 1 and 2 as described above. This manuscript has been submitted to a peerreviewed journal and is currently under review.
Aim 3 was to test the effect of conditionally deleting Aspm in mouse medulloblastoma after tumors formed. Dr. Garcia generated tumor-prone mice with tamoxifen-inducible deletion of Aspm. This experiment required the use of the slowly tumorigenic SmoA1 line, rather than the more rapidly tumor-inducing SmoM2 line used in Aim 2. The resulting mice are currently under study and have not yet reached an age at which tumors are expected to form. After the point of tumor formation, mice will be injected with tamoxifen to induce Aspm deletion and the effects on tumor growth and animal survival will be examined.
RESEARCH AND TRAINING ACCOMPLISHMENTS:
• Demonstration that Aspm regulated by Shh ( Fig. 1 attached manuscript) • Demonstration of Aspm in medulloblastoma ( Fig. 1 attached manuscript) • Demonstration that Aspm is required for postnatal brain growth ( Fig. 2 attached manuscript) • Finding of preserved proliferation with Aspm deletion (Fig. 3 attached manuscript) • Finding of increased apoptosis and DNA damage with Aspm loss (Fig. 4 attached manuscript) • Finding that p53 deletion rescues phenotype of Aspm deletion (Fig. 5 attached manuscript) • Finding that Aspm deletion limits medulloblastoma growth (Fig. 6 attached manuscript) REPORTABLE OUTCOMES:
• Manuscripts: Aspm sustains cerebellar growth and medulloblastoma formation by mitigating replication stress (submitted) • Development of animal models: Aspm knock out mice (Aspm -/-), Aspm conditional knockout mice (Aspm f/f ), medulloblastoma-prone Aspm conditional mice (Aspm f/f ;hGfap-cre;SmoM2)
• Employment or research opportunities received based on experience/training supported by this training award: Dr. Garcia was offered a second postdoctoral fellowship position at the BioDonostia Institute, San Sebstian, in the laboratory of Dr. Ander Matheu.
CONCLUSION: In the first year of this 3 year grant, the PI made striking findings that validated the overall hypothesis that microcephaly genes may be ideal new targets for brain tumor therapies. Dr. Garcia identified Aspm as a microcephaly gene that is overexpressed in medulloblastoma and required for tumor growth. In the course of this work, Dr. Garcia gained key expertise that enabled her to find a research position in her native country, where she will continue her brain tumor studies.
Summary
Microcephaly and medulloblastoma are disorders of neural development that result respectively from inadequate or excessive progenitor proliferation. patients with primary microcephaly have brains in which neuronal diversity is relatively preserved, but the overall size of the brain is markedly reduced (Woods et al., 2005) . In contrast, medulloblastoma demonstrates the pathological effect of over-amplifying progenitor populations. The most common malignant brain tumors in children, medulloblastomas are growing masses of monomorphic cells resembling neural progenitors. In their divergent pathologies, microcephaly and medulloblastoma underscore the importance of regulating symmetric cell division to control brain growth.
Aspm has been implicated in pathological states of both inadequate and excessive growth. Mutations in ASPM cause familial microcephaly (Bond et al., 2002; Bond et al., 2003; Woods et al., 2005) . Studies in mice show that Aspm is expressed by multi-potent neural stem cells at sites of cerebral neurogenesis (Bond et al., 2002; Marinaro et al., 2011) and that genetic deletion of Aspm reduces brain growth (Fish et al., 2006) . ASPM has also been detected in cancers, including gliomas (Horvath et al., 2006; Bikeye et al., 2010) , medulloblastomas (Vulcani-Freitas et al., 2011) , hepatocellular carcinomas (Lin et al., 2008) and cancers of the ovary (Bruning-Richardson et al., 2011) and pancreas (Wang et al., 2013) . Thus loss of Aspm function reduces growth, while aberrant expression of Aspm is associated with growth excess.
Various functions of Aspm have been identified. In Drosophila the orthologous gene, asp, maintains mitotic spindle orientation during both mitosis and meiosis (Zhonget al.2005; Kaindl et al. 2010) . The mouse homolog Aspm is required during brain development to maintain mitotic spindle organization and positioning and acts as a microtubule-organizing center (Higgins et al. 2010; Kaindl et al. 2010) . Recently, Aspm has been demonstrated to modulate progenitor proliferation and migration through an interaction with the Wnt developmental signaling pathway (Buchman et al., 2011) . While the net effect of these diverse functions is to support both physiologic and malignant proliferation, it is essential to determine how these functions converge to regulate cellular mechanisms of growth control.
The symmetrical divisions of cerebellar granule neuron progenitors (CGNPs) present an opportunity to study Aspm function in both brain growth and tumorigenesis.
CGNPs proliferate in the external granule layer (EGL) of the cerebellum to generate the largest population of neurons in the brain (Espinosa and Luo, 2008) . CGNPs are also proximal cells of origin for medulloblastoma Yang et al., 2008) .
Importantly specific developmental signaling molecules, including Shh and Wnt regulate both CGNP proliferation and medulloblastoma pathogenesis (Wechsler-Reya and Scott, 1999; Kenney and Rowitch, 2000; Zurawel et al., 2000; Ellison et al., 2011; Hatten and Roussel, 2011; Roussel and Hatten, 2011 ). Here we have found that Aspm is induced by Shh in CGNPs, that Aspm positively regulates cerebellar neurogenesis by mitigating replication stress, and that this function becomes co-opted in medulloblastoma.
Material and Methods

Mice
Transgenic Aspm-EGFP reporter mice (Tg(Aspm-EGFP)IH113Gsat/Mmucd) were obtained from GENSAT (New York, NY, USA) (Gong S et al. 2010) . Aspm-creER mice were generously shared by Luca Muzio, PhD, San Raffaele Scientific Institute, Milan, Italy and have been previously described (Marinaro et al., 2011 (Matei et al., 2005) . hGFAP-cre mice were generously provided by Eva Anton,PhD, University of North Carolina, Chapel Hill, NC, USA; these mice express cre during brain development in stem cells that give rise to diverse progeny, including the entire cerebellum (Zhuo et al., 2001) . SmoM2 
CGNP culture
CGNPs were isolated and explanted as previously described (Kenney et al., 2003) .
Cells were maintained in 0.5µg/ml of Shh (R&D Systems Minneapolis, MN, USA) or vehicle 0.5%BSA-PBS1x) as indicated.
RNA isolation and quantitative real-time PCR (qPCR)
Total RNA was isolated from cerebella, and from explanted CGNP using the RNeasy kit (Qiagen, Valencia, CA ,US), following manufacturer protocol. Oligo dT-proimed cDNA was synthesized from 1µg total RNA using the Superscript III kit (Invitrogen/Life technologies, Grand Island, NY, US).), per manufacturer protocol. Gene expression was quantified on an ABI PRISM 7500 Sequence Detection System, using the ΔΔC T relative quantification method. All experiments included no template controls and were performed in triplicate and repeated twice independently. Transcript levels were normalized to GAPDH reference gene. The primers used for the amplification of Aspm have been previously published and validated and were GCTTCATCACCTGCTCACCTAC and GTAGATACCGCTCCGCTTTCAG (Wu et al., 2008) . Additional primer pairs were Cyclin D2 GCGTGCAGAAGGACATCCA and CACTTTTGTTCCTCACAGACCTCTAG, GAPDH TGTGTCCGTCGTGGATCTGA and CCTGCTTCACCACCTTCTTGA.
In vivo proliferation analysis
Aspm-GFP mouse pups were injected at P7 IP with 50 µl HBSS containing EdU (250 µM, Invitrogen/Life technologies, Grand Island, NY, US). After 24 hours, brains were dissected and incubated in 4% formaldehyde in PBS for 24 hours at 4ºC, then processed for histology. EdU was detected following manufacturer's protocol.
Histology, immunochemistry and cell quantification.
Mouse brains were processed and immunohistochemistry was performed as previously described (Garcia et al. 2012; Gershon et al. 2009) 
Western blot analysis
Proteins of whole cerebella from Aspm +/+ and Aspm -/-mice were extracted and processed as previously described (Garcia et al. 2012) . Immunologic analysis was performed on a SNAP ID device (Millipore, Billerica, MA, USA) using primary antibodies to γH2AX and β-Actin (Cell Signaling, Boston, MA, USA, cat#4970).
Results
Aspm is induced by Shh and up-regulated during cerebellar neurogenesis
To visualize the cellular pattern of Aspm expression in the postnatal brain, we examined Aspm-GFP reporter mice generated by the Gensat project. To identify proliferating cells in these mice, we injected pups with EdU 24 hours before harvesting them. In the brains of mice at postnatal day 7 (P7), we noted that sites of GFP expression clorresponded with the sites postnatal neurogenesis, including the EGL (Fig 1A) . In the cerebellum, GFP expression followed the temporal pattern of CGNP proliferation, waning by P16 (Fig. 1B) . The relationship between Aspm expression and CGNP proliferation was further demonstrated by real-time, quantitative PCR (qPCR), as Aspm expression mirrored the expression of Cyclin D2, a previously identified marker of CGNP proliferation (Kenney and Rowitch, 2000) . The expression of both Cyclin D2 and Aspm was relatively high at peak neurogenesis (P7), and waned by the neurogenic period (P16; Fig. 1C ). Importantly, isolated CGNPs when maintained in a proliferative state by exposure to exogenous Shh, expressed significantly more Aspm mRNA compared to Shh-deprived CGNPs (Fig. 1C) ,
and CGNPs isolated from Aspm-GFP mice up-regulated GFP when maintained in Shh (Fig. 1D ).
To proliferation and predisposes these mice to medulloblastoma (Hallahan et al., 2004) . In
Aspm-GFP;ND2:SmoA1 mice, CGNPs proliferated beyond the typical period of 15 days, and continued to express the Aspm-GFP reporter (Fig. 1E) . As spontaneous medulloblastomas developed in Aspm-GFP;ND2:SmoA1 mice, the Aspm-GFP reporter was consistently expressed throughout the resulting tumors (n>15; Fig. 1F ). Activation of the Shh signaling pathway was thus sufficient to drive Aspm expression in vivo, and Aspm expression was a consistent feature of Shh-driven medulloblastoma.
To examine the fate of postnatal Aspm expressing progenitors, we bred AspmcreER;tdTomato mice, which express a tamoxifen-inducible, fluorescent reporter in Aspm expressing cells. We injected tamoxifen at P4 and P7, and then harvested the mice at P11. We detected red fluorescence, indicating Aspm+ lineage, in CGNPs of the EGL, in progenitors of the hippocampus and RMS, in CGNs of the IGL, and in small CD31+ blood vessels throughout all regions of the brain (Fig. 1G,H) . Thus in the post-natal brain, the set of cells that derive from Aspm-expressing progenitors includes neural progenitors, differentiated neurons, and capillary endothelial cells.
Aspm in CGNPs is required for cerebellar growth
To determine if Aspm function is critical to CGNP proliferation, we examined the effect of Aspm-deficiency on cerebellar growth. We generated Aspm-deficient mice from (Fig 2A) . The EGL of Aspm SA/SA mice was notably thinner at P13 compared to Aspm +/+ littermates, consistent with premature waning of the CGNP population (Fig 2B) .
Compared to Aspm SA/+ or Aspm +/+ littermates, Aspm SA/SA mice had smaller brains ( Fig. 2C) with smaller cerebella (Fig 2D) . Thus Aspm SA/SA mice phenocopied previously reported Aspm-deleted mice (Pulvers et al., 2010) , and Aspm-deficiency reduced the size of the cerebellum along with the rest of the brain.
To determine whether deletion of Aspm impaired cerebellar growth through a cell autonomous effect on CGNPs, we used conditional deletion to ablate Aspm in the Math1 lineage. We generated mice with conditional deletion of Aspm and crossed them with Math1-cre mice (Helms et al., 2000; Machold and Fishell, 2005; Matei et al., 2005) . Aspm mRNA abundance was reduced in cerebella of Math1-cre;Aspm fl/fl mice, compared to Math1-cre;Aspm f/+ littermates (Fig 2E) . While overall brain weight was relatively preserved in Aspm fl/fl ;Math1-cre mice (Fig. 2F) , cerebellum weight was significantly lower compared to littermate controls (Fig 2G) . Conditional deletion of Aspm in the Math1 lineage thus confirmed that Aspm maintains cerebellar growth by acting on CGNPs to support the expansion of their population.
Proliferation is not impaired Aspm-deficient CGNPs
Population growth integrates proliferation, differentiation and apoptosis (Haydar et al., 1999; Woods et al., 2005; Poulton et al., 2011 (Fig. 3B) . With the waning of proliferation at P13 and P15, mitoses were markedly less frequent in both genotypes, complicating quantification of PH3+ cells. We therefore compared the number of cells expressing proliferation marker PCNA, which is expressed more broadly during the cell cycle (Fig. 3C) (Fig. 3E) . Thus Aspm deficiency did not detectably reduce either proliferation in vivo, or proliferative response to Shh in vitro.
Aspm deficiency increases progenitor apoptosis and replication stress.
While Aspm deficiency did not impair neural progenitor proliferation, apoptosis of neural progenitors was significantly increased. We quantified apoptosis using IHC for cC3, and determining the fraction of cells in the EGL that were cC3+. We compared Aspm SA/SA and Aspm +/+ genotypes at P7 and P11. We have previously shown that cC3+ cells are rarely detected in the EGL wild-type mice (Garcia et al., 2012) . In contrast, apoptotic cells were significantly more frequent in the EGL of Aspm SA/SA mice ( Fig. 4A-C ). Increased apoptosis with Aspm deficiency was proportional to proliferation, highest at P7 and lower at P11. Conditional deletion of Aspm in CGNPs also increased apoptosis, as cC3+ cells were more frequent in the EGL of P7 Math1-cre;Aspm f/f mice compared to Math1-cre;Aspm f/+ controls (0.87% vs 0.23%, p=0.006). No significant difference was found between Math1-cre;Aspm f/+ and no cre littermates (data not shown). These data show that Aspm deficiency increased CGNP apoptosis in a cell autonomous manner that was linked to proliferation.
CGNPs are highly sensitive to apoptosis in response to genotoxic stress (Chong et al., 2000; Lee et al., 2012) . The known role of Aspm in mitotic spindle dynamics (Zhong et al., 2005; Fish et al., 2006; Higgins et al., 2010) suggested that the increased cell death with Aspm deficiency might be caused by increased chromosomal damage during mitosis.
Accordingly we used quantitative IHC for phosphorylated Histone H2AX (γH2AX) in order to determine if DNA damage was more frequent in Aspm-deficient CGNPs. We compared Aspm SA/SA and Aspm +/+ genotypes at P7 and P11. We found scattered γH2AX+ cells in the EGL in all mice (Fig. 4D,E) , demonstrating that typical CGNP proliferation causes detectable replication stress. Aspm SA/SA mice had significantly more γH2AX+ CGNPs in the EGL at P7, compared to Aspm +/+ mice (Fig. 4E,F) . In contrast, at P11, when proliferation was waning, the effect of Aspm deficiency was markedly reduced. Thus Aspm deficiency increased the rate of proliferation-related DNA damage during postnatal neurogenesis, identifying increased replication stress as a potential mechanism inducing progenitor apoptosis with Aspm loss of function.
P53 deletion rescues Aspm-induced microcephaly
Replication stress can trigger neural progenitor apoptosis through p53 dependent mechanisms (Vousden and Lu, 2002; Fridman and Lowe, 2003; Lee and McKinnon, 2007) . To determine if increased replication stress was the cause of CGNP apoptosis and growth restriction in Aspm-deficient mice, we investigated whether deletion of p53 rescued Aspm-deficient CGNPs. We crossed Math1-cre;Aspm f/f and p53 f/f mouse lines and selected Math1-cre;Aspm f/f ;p53 +/+ and Math1-cre;Aspm f/f ;p53 f/f progeny for comparison. We harvested mice at P7 and compared the rates of apoptosis, DNA damage, and proliferation, by determining the proportion of cells in the EGL that were, respectively cC3+, γH2AX+ and PH3+. We found that CGNP apoptosis was significantly reduced in Math1-cre;Aspm f/f ;p53 f/f mice, compared to Math1-cre;Aspm f/f mice with wild type p53 (Fig.   5A ). In contrast, we did not detect significant changes in DNA damage or proliferation rate (Fig. 5B,C) . We then raised Math1-cre;Aspm f/f ;p53 f/f mice to P30 and compared cerebellum weight to that of Math1-cre;Aspm f/f mice with wild type p53. We found that cerebellum weight was significantly increased by deletion of p53 (Fig. 5D ). Taken together, these data support a model in which Aspm supports brain growth by reducing replication stress during neural progenitor proliferation.
Aspm deficiency slows the growth of medulloblastoma
Because of the consistent finding of Aspm up-regulation in medulloblastoma, both ND2:SmoA1 mice (Fig.1F) We found that Aspm-deficient medulloblastomas grew significantly more slowly than tumors with an intact Aspm allele. The rate of tumor formation was 100% in both genotypes. Tumors could be differentiated from normal brain at P3, and at this early point, tumor size appeared to be similar in Aspm fl/fl or Aspm fl/+ mice (Fig. 6A,C) . Between P3 and P13, however, Aspm fl/fl tumors grew more slowly than Aspm fl/+ tumors, such that by P13
Aspm-deficient tumors were significantly smaller (Fig. 6B,D) . Comparison of the ratios of tumor to non-tumor cerebellum at P13 demonstrated significant difference in the rate of tumor growth (Fig. 6E) . Within tumors of both genotypes, γH2AX+ cells were too numerous and densely packed to be quantified by IHC. Using Western blot, however, we consistently found significantly increased γH2AX+ in Aspm-deleted tumors at P3 (Fig. 6F) . By P13, however, γH2AX+ abundance was equivalent (data not shown), suggesting that tumors had developed a mechanism to compensate for Aspm deletion. Consistent with the evolution of resistance within tumors, hGFAP-cre;SmoM2;Aspm fl/fl mice demonstrated progressive neurologic abnormality, could not be weaned, and did not survive longer than hGFAP-cre;SmoM2;Aspmf/+ mice with more rapidly expanding tumors. Thus, while we did not detect a survival benefit, Aspm deletion impacted malignant growth in a manner similar to physiologic development, increasing replication stress during medulloblastoma tumorigenesis and restricting tumor growth.
Discussion
In this investigation, we have shown that Aspm reduces replication stress during both physiologic and malignant proliferation, and that Aspm deletion causes microcephaly by increasing progenitor cell death. We found that Aspm is induced in CGNPs by Shh signaling and remains up-regulated in in Shh-induced medulloblastoma. Aspm disruption reduced brain growth globally and conditional deletion of Aspm in CGNPs similarly restricted the growth of the cerebellum. Importantly, Aspm deletion did not reduce CGNP proliferation, but rather increased CGNP apoptosis. The increased cell death associated with Aspm deletion was accompanied by increased DNA damage in proliferating CGNPs.
Aspm deletion also increased DNA damage early in the process of medulloblastoma pathogenesis and coincided with restricted tumor growth between P3 and P13. Apoptosis of Aspm-deficient CGNPs was prevented by co-deletion of p53, consistent with genotoxic injury as the cause of cell death. Moreover, the restoration of cerebellar growth in mice with co-deletion of Aspm and p53 demonstrates that preventing apoptosis can rescue Aspm-dependent growth restriction.
Human and mouse studies have shown that microcephaly can result from either loss of progenitor self-renewal, as in premature differentiation of Nde1-deleted progenitors (Pawlisz et al., 2008) , or from progenitor apoptosis, as seen in Cdk5rap2 mutation (Pawlisz et al., 2008; Lizarraga et al., 2010) . These two mechanisms may also operate simultaneously, for example centrosome amplification (Marthiens et al., 2013) and Magoh mutation (Silver et al., 2010) cause microcephaly by inducing both apoptosis and loss of self-renewal in neural progenitors. In all of these examples, the phenotype produced in mice is severe brain malformation. In both our genetic model and an independent genetrap model, however, Aspm deletion produced a phenotype in mice that is much less severe than the orthologous phenotype in humans (Pulvers et al., 2010) . This variance from the typical pattern of microcephaly genes suggests that the mechanism of microcephaly in Aspm deletion may be critically different.
Our data indicate that loss of Aspm function restricts brain growth by modestly increasing the probability of progenitor cell death during symmetric cell division. Increased DNA damage mediates this increased risk of apoptosis. Specific genes, for example, Atr, have been shown to be required for symmetric cell division without lethal replication stress (Lee et al., 2012) . Unlike Atr, however, which causes severe phenotype when deleted, Aspm is not required for most symmetric divisions to produce viable progeny. We have previously shown that even a very low rate of apoptosis, detectable only by comparing to apoptosis-deficient, Bax-deleted mice, exerts a significant impact on cerebellar growth (Garcia et al., 2012) . We propose that Aspm loss imposes a cost to the developing brain through increased apoptosis that is proportional to the requirement of the organism for brain growth; thus Aspm deletion is more eloquent in humans, in which brain size is larger and the period of brain growth is more prolonged. 
